Key terms
About BSX
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BSX news
Mar 07
7:24am ET
Boston Scientific price target raised to $77 from $65 at TD Cowen
Mar 07
4:21am ET
Analysts Are Bullish on Top Healthcare Stocks: Viking Therapeutics (VKTX), Boston Scientific (BSX)
Mar 06
7:35am ET
Piper Sandler Keeps Their Buy Rating on Boston Scientific (BSX)
Mar 03
10:33am ET
Analysts Conflicted on These Healthcare Names: Boston Scientific (BSX), ANI Pharmaceuticals (ANIP) and Merck & Company (MRK)
Mar 01
6:57am ET
Boston Scientific receives FDA approval for Farapulse PFA System
Feb 29
6:30am ET
Boston Scientific (BSX) Receives a Buy from Wells Fargo
Feb 27
7:51am ET
Analysts Are Bullish on Top Healthcare Stocks: ANI Pharmaceuticals (ANIP), Boston Scientific (BSX)
Feb 06
5:38am ET
Boston Scientific’s Farapulse Poised for Growth on Positive Physician Sentiment and Anticipated Reimbursement Incentives
Feb 05
8:10am ET
Analysts Are Bullish on Top Healthcare Stocks: 4D Molecular Therapeutics (FDMT), Boston Scientific (BSX)
Feb 02
10:48am ET
Wells upgrades Edwards Lifesciences, says tricuspid opportunity underappreciated
Feb 01
8:10pm ET
Boston Scientific price target raised to $70 from $60 at Barclays
Feb 01
9:58am ET
Qualcomm downgraded, Cigna upgraded: Wall Street’s top analyst calls
Feb 01
8:49am ET
Boston Scientific price target raised to $63 from $55 at Deutsche Bank
Feb 01
8:25am ET
Boston Scientific price target raised to $73 from $70 at Truist
Feb 01
8:00am ET
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Insmed (INSM) and Amgen (AMGN)
Feb 01
7:54am ET
Boston Scientific price target raised to $81 from $77 at Canaccord
Feb 01
7:49am ET
Boston Scientific price target raised to $70 from $67 at RBC Capital
Feb 01
7:47am ET
Mizuho upgrades Boston Scientific to Buy on durable growth
Feb 01
7:43am ET
Boston Scientific upgraded to Buy from Neutral at Mizuho
Feb 01
7:11am ET
Analysts Are Bullish on Top Healthcare Stocks: Boston Scientific (BSX), Teladoc (TDOC)
Feb 01
6:50am ET
Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX), Humana (HUM) and Boston Scientific (BSX)
Feb 01
6:30am ET
Boston Scientific price target raised to $71 from $65 at Citi
Jan 31
4:25pm ET
Boston Scientific: A Strong Buy on Robust Financials and Promising FDA Approvals
Jan 31
9:20am ET
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Novo Nordisk (NVO) and Boston Scientific (BSX)
Jan 31
8:05am ET
Boston Scientific (NYSE:BSX) Surges on Stellar Q4 Results
Jan 31
6:35am ET
Boston Scientific sees FY24 adjusted EPS $2.23-$2.27, consensus $2.24
Jan 31
6:33am ET
Boston Scientific sees Q1 EPS 50c-52c, consensus 52c
Jan 31
6:32am ET
Boston Scientific reports Q4 adjusted EPS 55c, consensus 51c
Jan 31
6:29am ET
Boston Scientific receives FDA approval for Farapulse PFA System
Jan 30
9:25pm ET
Truist Financial Sticks to Their Buy Rating for Boston Scientific (BSX)
Jan 29
1:45pm ET
Boston Scientific call volume above normal and directionally bullish
No recent news articles are available for BSX
No recent press releases are available for BSX
BSX Financials
Key terms
Ad Feedback
BSX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BSX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range